Clinical Trials on Neuroendocrine Tumor Grade 3 in Australia
Total 356 results
-
IpsenCompletedGastro-Enteropancreatic Neuroendocrine TumorUnited States, Austria, Denmark
-
Australasian Gastro-Intestinal Trials GroupCompletedMidgut Neuroendocrine Tumours | Pancreatic Neuroendocrine TumoursAustralia
-
Provectus Biopharmaceuticals, Inc.Active, not recruitingNeuroendocrine Tumors Metastatic to the LiverAustralia
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedUnspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)Australia, United States
-
Melanoma and Skin Cancer Trials LimitedRecruitingMetastatic Merkel Cell CarcinomaAustralia
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbActive, not recruiting
-
Trans Tasman Radiation Oncology GroupCompleted
-
Barwon HealthAustralasian Gastro-Intestinal Trials Group; Deakin University; Specialised Therapeutics...UnknownGastrointestinal Neuroendocrine CarcinomasAustralia
-
Camurus ABActive, not recruitingGastro-enteropancreatic Neuroendocrine TumorUnited States, Belgium, Spain, Netherlands, France, Germany, Israel, Italy, Canada, Australia, Romania, Hungary
-
IpsenActive, not recruitingNeuroendocrine TumorsAustria, Denmark, Switzerland, Australia, United Kingdom, France
-
Rigel PharmaceuticalsNationwide Children's HospitalNot yet recruitingAstrocytoma | High Grade Glioma | Oligodendroglioma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | Spinal Tumor | Astrocytoma, Grade III | Astrocytoma, Grade IV | IDH1 Mutation | WHO Grade IV Glioma | Thalamus Tumor | IDH1 R132 | IDH1 R132C | IDH1 R132H and other conditionsUnited States, Australia, United Kingdom, Canada, Germany, Netherlands
-
Melanoma and Skin Cancer Trials LimitedRecruitingNeuroendocrine Tumors | Merkel Cell Carcinoma | Merkel Cell Carcinoma, Stage I | Merkel Cell Carcinoma, Stage II | Merkel Cell Carcinoma, Stage III | Carcinoma Neuroendocrine SkinAustralia, New Zealand
-
Lipotek Pty LtdRoyal Adelaide Hospital; Trident Clinical Research Pty LtdCompleted
-
IpsenTerminated
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Clarity Pharmaceuticals LtdActive, not recruitingNeuroendocrine TumorsAustralia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingNeuroendocrine TumorsAustralia
-
IpsenTerminatedNeuroendocrine TumorsUnited States, Australia, Austria, Canada, Denmark, France, Switzerland, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaRecruiting
-
Bristol-Myers SquibbCompleted
-
Jagiellonian UniversityMedical University Innsbruck; University Medical Centre Ljubljana; University... and other collaboratorsCompletedNeuroendocrine TumorsAustria, Poland, Slovenia
-
Ludwig Institute for Cancer ResearchBristol-Myers SquibbTerminatedMetastatic MelanomaAustralia
-
Immutep Australia Pty. Ltd.CompletedStage IV Melanoma | Stage III MelanomaAustralia
-
IpsenTerminatedNeuroendocrine TumoursUnited Kingdom, France, Germany, Australia, Italy
-
IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsGermany, Austria
-
Australasian Gastro-Intestinal Trials GroupCanadian Cancer Trials GroupNot yet recruitingNeuroendocrine TumorsAustralia
-
Ludwig Institute for Cancer ResearchAustin Health; Peter MacCallum Cancer InstituteCompleted
-
Cooperative Research Centre for Biomedical Imaging...Unknown
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
Arcispedale Santa Maria Nuova-IRCCSCompletedNeuroendocrine TumoursAustria, Italy
-
Xennials Therapeutics Australia Pty LtdPinotbio, Inc.TerminatedAdvanced Solid Tumor | High-grade Glioma | Platinum-Resistant Ovarian Cancer | Platinum-Resistant Urothelial CarcinomaAustralia
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedMelanomaAustralia, United States
-
PfizerCompletedWell-differentiated Pancreatic Neuroendocrine TumorUnited States, China, Czechia, India, Japan, South Africa, Slovakia, France, Norway, Romania, Australia, Belgium, Hungary, Italy, Spain
-
Philogen S.p.A.Immatics Biotechnologies GmbHTerminatedMerkel Cell CarcinomaGermany, Austria, Denmark, France, Spain, United Kingdom
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCNot yet recruitingMucosal MelanomaAustralia
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Melanoma Institute AustraliaNovartisRecruiting
-
Provectus PharmaceuticalsCompleted
-
Medical University InnsbruckNovartisCompletedNeuroendocrine TumorsAustria
-
QBiotics Group LimitedMerck Sharp & Dohme LLCTerminated
-
University Hospital, ToursEuropean Academy of Dermatology and VenerologyNot yet recruitingMerkel Cell CarcinomaUnited Kingdom, Austria, Finland, France, Germany, Italy, Netherlands, Romania, Sweden, Turkey
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
QBiotics Group LimitedTerminated
-
Provectus PharmaceuticalsCompleted
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
Nationwide Children's HospitalNovartisNot yet recruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | WHO Grade III Glioma | Metastatic Brain Tumor | WHO Grade IV GliomaUnited States, Australia, United Kingdom, Canada, Germany, Netherlands